Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Avanos Medical
(NYSE:AVNS)
Intraday
$17.85
-0.86
[-4.60%]
After-Hours
$17.85
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$17.85
-0.86
[-4.60%]
At close: Apr 25
$17.85
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Avanos Medical Stock (NYSE:AVNS)
Avanos Medical Stock (NYSE: AVNS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, February 22, 2024
Avanos Medical Voluntarily Recalled Specific Lots Of MIC* Gastric – Jejunal Feeding Tube Kits In Response To Nurse Assist Sterile Water Medical Products Recall
Benzinga Newsdesk
-
Feb 22, 2024, 1:53AM
Tuesday, February 20, 2024
CORRECTION: Avanos Medical Q4 Adj. EPS $0.36 Misses $0.37 Estimate, Sales $173.30M Beat $170.43M Estimate
Benzinga Newsdesk
-
Feb 20, 2024, 7:01PM
Avanos Medical Expects 2024 Net Sales of $685M-$705M Vs $690.13M Est, Adj EPS of $1.30-$1.45 Vs $1.38 Est
Benzinga Newsdesk
-
Feb 20, 2024, 7:06AM
Earnings Scheduled For February 20, 2024
Benzinga Insights
-
Feb 20, 2024, 6:52AM
Thursday, January 04, 2024
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Jan 4, 2024, 1:37PM
Avanos Medical shares are trading lower after the company reported preliminary Q4 and FY23 financial results and revised preliminary 2024 revenue guidance.
Benzinga Newsdesk
-
Jan 4, 2024, 10:57AM
Avanos Medical, Inc. Reports Preliminary Q4 And FY23 Financial Results; Revises Preliminary 2024 Revenue Outlook; Sees Q4 Revenue $170M-$173M Vs $179.27M Est.; FY23 Revenue $670M-$673M Vs $679.27M Est. ; FY24 Revenue $685M-$705M Vs $714.43M Est.
Benzinga Newsdesk
-
Jan 4, 2024, 8:35AM
Wednesday, November 01, 2023
Avanos Medical shares are trading higher following better-than-expected Q3 results.
Benzinga Newsdesk
-
Nov 1, 2023, 12:44PM
Garmin, Apollo Global Management, Trane Technologies, Scotts Miracle-Gro And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
-
Nov 1, 2023, 11:09AM
Avanos Medical Expects FY23 Revenue Between $675M-$685M Vs. 680.63M Estimate, Expects FY23 Adjusted EPS Of $1.05-$1.15 Vs. 1.09 Estimate (Prior Outlook: $1.05-$1.15)
Benzinga Newsdesk
-
Nov 1, 2023, 7:21AM
Earnings Scheduled For November 1, 2023
Benzinga Insights
-
Nov 1, 2023, 7:19AM
Avanos Medical Q3 Adj. EPS $0.30 Beats $0.28 Estimate, Sales $171.30M Beat $169.60M Estimate
Benzinga Newsdesk
-
Nov 1, 2023, 7:16AM
Tuesday, October 31, 2023
Earnings Outlook For Avanos Medical
Benzinga Insights
-
Oct 31, 2023, 4:03PM
Wednesday, August 09, 2023
Avanos Medical Shares Resume Trade
Happy Mohamed
-
Aug 9, 2023, 10:56AM
Avanos Medical Shares Halted, News Pending
Benzinga Newsdesk
-
Aug 9, 2023, 8:43AM
Avanos Medical Expects Adjusted Diluted EPS Of $1.05-$1.15 For FY23, Vs. Consensus Of $1.52
Benzinga Newsdesk
-
Aug 9, 2023, 7:22AM
Avanos Medical Q2 Adj. EPS $0.24 Misses $0.30 Estimate, Sales $169.40M Miss $186.22M Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 7:04AM
Earnings Scheduled For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 4:54AM
Tuesday, July 25, 2023
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Benzinga Insights
-
Jul 25, 2023, 11:00AM
Keybanc Downgrades Avanos Medical to Sector Weight
Benzinga Newsdesk
-
Jul 25, 2023, 4:05AM
Wednesday, June 21, 2023
Stifel Reiterates Hold on Avanos Medical, Maintains $25 Price Target
Benzinga Newsdesk
-
Jun 21, 2023, 9:38AM
Monday, June 19, 2023
Avanos Medical Earlier Monday Announced Agreement to Acquire Diros Technology; Terms Not Disclosed
Charles Gross
-
Jun 19, 2023, 7:13PM
Thursday, June 08, 2023
Avanos Medical Divests Respiratory Health Business To SunMed
Nabaparna Bhattacharya
-
Jun 8, 2023, 10:10AM
Avanos Medical Has Agreed To Sell Its Respiratory Health Business To SunMed, Including Ballard, Microcuff and endOclear brands – and long-term leases for two manufacturing facilities In Mexico; Deal Terms Were Not Disclosed
Benzinga Newsdesk
-
Jun 8, 2023, 6:53AM
Monday, May 22, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Benzinga Insights
-
May 22, 2023, 11:00AM
CL King Initiates Coverage On Avanos Medical with Buy Rating, Announces Price Target of $31
Benzinga Newsdesk
-
May 22, 2023, 9:45AM
Thursday, May 11, 2023
Avanos Medical Earnings Perspective: Return On Capital Employed
Benzinga Insights
-
May 11, 2023, 10:51AM
Thursday, May 04, 2023
Morgan Stanley Maintains Underweight on Avanos Medical, Lowers Price Target to $26
Benzinga Newsdesk
-
May 4, 2023, 8:53AM
Wednesday, May 03, 2023
Avanos Medical shares are trading lower after the company reported worse-than-expected Q1 sales results.
Benzinga Newsdesk
-
May 3, 2023, 11:48AM
Estee Lauder, NerdWallet, Sprout Social And Other Big Stocks Moving Lower On Wednesday
Lisa Levin
-
May 3, 2023, 11:11AM
Avanos Medical Q1 Adjusted EPS $0.27, Inline, Sales $191.70M Miss $195.20M Estimate
Benzinga Newsdesk
-
May 3, 2023, 7:08AM
Recap: Avanos Medical Q1 Earnings
Benzinga Insights
-
May 3, 2023, 7:06AM
Friday, April 21, 2023
Avanos Medical Recalls Certain BALLARD ACCESS Closed Suction Systems For Pediatric Use Citing Ventilation Risk
Vandana Singh
-
Apr 21, 2023, 11:31AM
FDA Says Avanos Medical Inc Recalls Certain Ballard Access Closed Suction Systems For Neonates/Pediatrics; Avanos Medical Recalls Some Ballard Access Closed Suction Systems For Neonates/Pediatrics After Complaints About Cracked Manifolds During Use
Happy Mohamed
-
Apr 21, 2023, 8:54AM
Wednesday, February 22, 2023
Looking Into Avanos Medical's Return On Invested Capital
Benzinga Insights
-
Feb 22, 2023, 9:48AM
Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $28
Benzinga Newsdesk
-
Feb 22, 2023, 8:50AM
Tuesday, February 21, 2023
Avanos Medical Sees FY23 Adjusted EPS Of $1.60-$1.80 Vs. $1.68 Estimate
Benzinga Newsdesk
-
Feb 21, 2023, 7:07AM
Avanos Medical Q4 Adjusted EPS $0.60 Beats $0.49 Estimate, Sales $217.50M Beat $217.30M Estimate
Benzinga Newsdesk
-
Feb 21, 2023, 7:05AM
Earnings Scheduled For February 21, 2023
Benzinga Insights
-
Feb 21, 2023, 5:20AM
Monday, February 20, 2023
Earnings Outlook For Avanos Medical
Benzinga Insights
-
Feb 20, 2023, 12:01PM
Wednesday, January 11, 2023
Avanos Medical: Pursuant To Transformation Processco Plans To Combine Chronic Care & Pain Franchises Into Single Commercial Organization
Bill Haddad
-
Jan 11, 2023, 7:30AM
Avanos Medical, Inc On Jan. 10 Approved Three-year Transformation Process, Plans To Exit Certain Low-margin, Low-growth Product Categories, Including Through Targeted Divestitures
Bill Haddad
-
Jan 11, 2023, 7:30AM
Friday, January 06, 2023
Morgan Stanley Maintains Underweight on Avanos Medical, Raises Price Target to $26
Benzinga Newsdesk
-
Jan 6, 2023, 8:50AM
Thursday, November 03, 2022
Keybanc Maintains Overweight on Avanos Medical, Lowers Price Target to $34
Benzinga Newsdesk
-
Nov 3, 2022, 4:29AM
Wednesday, November 02, 2022
Recap: Avanos Medical Q3 Earnings
Benzinga Insights
-
Nov 2, 2022, 7:51AM
Avanos Reaffirms 2022 Guidance
Benzinga Newsdesk
-
Nov 2, 2022, 7:04AM
Avanos Medical Q3 EPS $0.38 Beats $0.35 Estimate, Sales $202.00M Miss $205.47M Estimate
Benzinga Newsdesk
-
Nov 2, 2022, 7:04AM
Earnings Scheduled For November 2, 2022
Benzinga Insights
-
Nov 2, 2022, 4:37AM
Wednesday, October 12, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
-
Oct 12, 2022, 1:32PM
Tuesday, October 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 11, 2022, 12:47PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch